Open Access
Editorial
| Issue |
Vis Cancer Med
Volume 5, 2024
|
|
|---|---|---|
| Article Number | E3 | |
| Number of page(s) | 4 | |
| DOI | https://doi.org/10.1051/vcm/2024009 | |
| Published online | 31 October 2024 | |
- Allemani C, Matsuda T, Di Carlo V, et al. CONCORD Working Group. CONCORD Working Group. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries, Lancet. 2018;391(10125):1023–1075. [CrossRef] [PubMed] [Google Scholar]
- Zeng HM, Zheng RS, Sun KX, et al. Cancer survival statistics in China 2019–2021: a multicenter, population-based study. J Natl Cancer Center 2024;4:203–213. [CrossRef] [Google Scholar]
- Lu Z, Chen Y, Liu D, et al. The landscape of cancer research and cancer care in China, Nat Med 2023;29(12):3022–3032. [CrossRef] [PubMed] [Google Scholar]
- Zhao S, Zhao H, Lv C, et al. Anticancer drug R&D landscape in China, J Hematol Oncol 2020;13(1):51. [CrossRef] [PubMed] [Google Scholar]
- Zhou Q, Chen XY, Yang ZM, Wu YL. The changing landscape of clinical trial and approval processes in China. Nat Rev Clin Oncol 2017;14(9):577–583. [CrossRef] [PubMed] [Google Scholar]
- Sun X, Tan J, Tang L, et al. Real world evidence: experience and lessons from China, BMJ. 2018;360:j5262. [CrossRef] [PubMed] [Google Scholar]
- Chen Z, Liu X, Hogan W, et al. Applications of artificial intelligence in drug development using real-world data, Drug Discov Today. 2021;26(5):1256–1264. [CrossRef] [PubMed] [Google Scholar]
- Knevel R, Liao KP, From real-world electronic health record data to real-world results using artificial intelligence. Ann Rheum Dis. 2023;82(3):306–311. [CrossRef] [PubMed] [Google Scholar]
- Liao X, Yao C, Zhang J, et al. Recent advancement in integrating artificial intelligence and information technology with real-world data for clinical decision-making in China: A scoping review. J Evid Based Med. 2023;16(4):534–546. [CrossRef] [PubMed] [Google Scholar]
- Aydin F, Yildirim ÖT, Aydin AH, et al. Comparison of artificial intelligence-assisted informed consent obtained before coronary angiography with the conventional method: Medical competence and ethical assessment, Digit Health. 2023;9:20552076231218141. [CrossRef] [PubMed] [Google Scholar]
- Laurent T, Lambrelli D, Wakabayashi R, et al. Strategies to address current challenges in real-world evidence generation in Japan, Drugs Real World Outcomes. 2023;10(2):167–176. [CrossRef] [PubMed] [Google Scholar]
- Sherman RE, Anderson SA, Dal Pan GJ, et al. Real-world evidence – What is it and what can it tell us?, N Engl J Med. 2016;375(23):2293–2297. [CrossRef] [PubMed] [Google Scholar]
- Galtier M, Meadon D, Applying AI to real-world health-care settings and the life sciences: Tackling data privacy, security and policy challenges with federated learning. Artificial Intelligence in Science Challenges, Opportunities and the Future of Research 2023;170. [Google Scholar]
- Reddy S, Explainability and artificial intelligence in medicine. Lancet Digit Health 2022;4(4):e214–e215. [CrossRef] [PubMed] [Google Scholar]
- Hutson M, How AI is being used to accelerate clinical trials. Nature 2024;627(8003):S2–S5. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.